Miragen Therapeutics, Inc.
Extract: Charter Amendment (Plain English Desc) from a 8-K on 01/04/2021   Download
SEC Document
SEC Filing
On January 4, 2021, Miragen Therapeutics, Inc. (the “Company”) implemented an increase in the number of authorized shares of its Common Stock from 100,000,000 to 200,000,000 pursuant to a Certificate of Amendment to the Company’s Certificate of Incorporation, a copy of which is filed herewith as Exhibit 3.1.